One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: Outcome and predictors of remission

被引:47
作者
Heldt, Elizeth
Manfro, Gisele Gus
Kipper, Leticia
Blaya, Carolina
Isolan, Luciano
Otto, Michael W.
机构
[1] Univ Fed Rio Grande Sul, Post Grad Program Med Sci Psychiat, BR-90046900 Porto Alegre, RS, Brazil
[2] Hosp Clin Porto Alegre, Anxiety Disorders Program, Porto Alegre, RS, Brazil
[3] Boston Univ, Ctr Anxiety Related Disorders, Boston, MA 02215 USA
关键词
panic disorder; cognitive-behavior therapy; group therapy; Co morbidity; follow-up;
D O I
10.1016/j.brat.2005.05.003
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Non-response to pharmacotherapy for panic disorder (PD) is a well-documented problem. However, little information exists to guide next-step strategies for these non-responders. In addition to pharmacologic augmentation strategies, several studies support the efficacy of cognitive-behavior therapy (CBT) for these patients, although data on long-term outcomes has been lacking. In this study, we provide one-year outcomes on a sample of 63 patients who completed group CBT for PD after failing to respond adequately to previous pharmacotherapy. Sustained significant benefit was found for all dimensional outcome scores, and nearly two-thirds of the sample met remission criteria. This occurred with reductions in medication use over the follow-up period. Negative predictors of remission status included comorbid dysthymia, social phobia, and generalized anxiety disorder. These results provide additional evidence for the efficacy of CBT for medication non-responders with PD. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:657 / 665
页数:9
相关论文
共 25 条
[11]   Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial [J].
Hirschmann, S ;
Dannon, PN ;
Iancu, I ;
Dolberg, OT ;
Zohar, J ;
Grunhaus, L .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (05) :556-559
[12]   REMISSION AND RELAPSE IN SUBJECTS WITH PANIC DISORDER AND PANIC WITH AGORAPHOBIA - A PROSPECTIVE SHORT-INTERVAL NATURALISTIC FOLLOW-UP [J].
KELLER, MB ;
YONKERS, KA ;
WARSHAW, MG ;
PRATT, LA ;
GOLLAN, JK ;
MASSION, AO ;
WHITE, K ;
SWARTZ, AR ;
REICH, J ;
LAVORI, PW .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1994, 182 (05) :290-296
[13]   Usefulness of olanzapine in refractory panic attacks [J].
Khaldi, S ;
Kornreich, C ;
Dan, B ;
Pelc, I .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (01) :100-101
[14]   Cognitive-behavioral group therapy for panic disorder in the general clinical setting: A naturalistic study with 1-year follow-up [J].
Martinsen, EW ;
Olsen, T ;
Tonset, E ;
Nyland, KE ;
Aarre, TF .
JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 (08) :437-442
[15]  
Orvaschel H., 1987, SCHEDULE AFFECTIVE D
[16]  
Otto M.W., 1996, STOPPING ANXIETY MED
[17]   Benzodiazepine discontinuation difficulties in panic disorder: Conceptual model and outcome for cognitive-behavior therapy [J].
Otto, MW ;
Hong, JJ ;
Safren, SA .
CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (01) :75-80
[18]   An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder [J].
Otto, MW ;
Tuby, KS ;
Gould, RA ;
McLean, RYS ;
Pollack, MH .
AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (12) :1989-1992
[19]   Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series [J].
Otto, MW ;
Pollack, MH ;
Penava, SJ ;
Zucker, BG .
BEHAVIOUR RESEARCH AND THERAPY, 1999, 37 (08) :763-770
[20]   Gabapentin as a potential treatment for anxiety disorders [J].
Pollack, MH ;
Matthews, J ;
Scott, EL .
AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (07) :992-993